tradingkey.logo

TELA Bio Inc

TELA
0.811USD
+0.011+1.35%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
32.71MMarktkapitalisierung
VerlustKGV TTM

TELA Bio Inc

0.811
+0.011+1.35%

mehr Informationen über TELA Bio Inc Unternehmen

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc Informationen

BörsenkürzelTELA
Name des UnternehmensTELA Bio Inc
IPO-datumNov 08, 2019
CEOKoblish (Antony)
Anzahl der mitarbeiter209
WertpapierartOrdinary Share
GeschäftsjahresendeNov 08
Addresse1 Great Valley Parkway, Suite 24
StadtMALVERN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl19355
Telefon14843202930
Websitehttps://www.telabio.com/
BörsenkürzelTELA
IPO-datumNov 08, 2019
CEOKoblish (Antony)

Führungskräfte von TELA Bio Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-93591.00%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+104800.00%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-23535.00%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+7950.00%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.93K
+11925.00%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-93591.00%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+104800.00%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-23535.00%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+7950.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
OviTex
25.32M
64.56%
OviTex PRS
13.12M
33.47%
Other
771.00K
1.97%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
OviTex
25.32M
64.56%
OviTex PRS
13.12M
33.47%
Other
771.00K
1.97%

Aktionärsstatistik

Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
Andere
49.38%
Aktionäre
Aktionäre
Anteil
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
Andere
49.38%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
33.24%
Venture Capital
17.62%
Investment Advisor
14.30%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
8.53%
Research Firm
1.77%
Andere
15.87%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
161
33.13M
75.68%
-6.50M
2025Q3
171
28.74M
72.54%
-9.88M
2025Q2
185
33.40M
84.44%
-6.87M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
EW Healthcare Partners
7.71M
17.62%
+3.60M
+87.67%
Nov 17, 2025
Nantahala Capital Management, LLC
5.11M
11.68%
--
--
Sep 30, 2025
North Run Capital, LP
3.68M
8.41%
+1.70M
+85.75%
Mar 31, 2025
Lytton (Laurence W)
2.87M
6.55%
+141.11K
+5.18%
Sep 30, 2025
SilverArc Capital Management, LLC
2.78M
6.36%
+3.13K
+0.11%
Sep 30, 2025
Stonepine Capital Management, LLC
2.16M
4.92%
+71.76K
+3.44%
Sep 30, 2025
The Vanguard Group, Inc.
1.80M
4.11%
-111.69K
-5.84%
Sep 30, 2025
UBS Financial Services, Inc.
216.80K
0.5%
-28.75K
-11.71%
Sep 30, 2025
Dafna Capital Management, LLC
1.44M
3.29%
--
--
Sep 30, 2025
Perkins Capital Management, Inc.
833.93K
1.91%
-41.94K
-4.79%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0%
iShares Russell 2000 Growth ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%
Global X Russell 2000 ETF
Anteil0%
Global X Russell 2000 Covered Call ETF
Anteil0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
Proshares Ultra Russell 2000
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI